Journal of Clinical Hypertension · 2015 · 26 citations · 25 references
PharmacyCardiologyPharmacoeconomicsClinical PharmacologyPharmaceutical ComplianceTherapeutic Drug MonitoringBlood Pressure ManagementHypertension ManagementMedication AdherenceAdherence To Antihypertensive TherapyAntihypertensive Medication AdherenceDiagnostic Testing AccuracyMedication NonadherenceNonadherenceRetrospective Cost AnalysisRoutine ScreeningTreatment-resistant Hypertension
Primary aldosteronism (PA) is present in up to 20% of patients with treatment-resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50% of patients with TRH are nonadherent to their prescribed antihypertensive medications. However, the relationship between the prevalence of PA and medication adherence as confirmed by TDM has not been previously assessed. A retrospective analysis from a hypertension referral clinic showed that prevalence of PA in adherent patients with TRH by TDM was significantly higher than in nonadherent patients (28% vs 8%, P<.05). Furthermore, cost analysis showed that TDM-guided PA screening was $590.69 less expensive per patient, with minimal impact on the diagnostic accuracy. These data support a TDM-guided PA screening approach as a cost-saving strategy compared with routine PA screening for TRH.
25
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
David A. Calhoun, Daniel Jones, Stephen C. Textor et al. · Circulation · 2008 · 2.2K citations · Full text
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
Thomas G. Pickering, John E. Hall, Lawrence J. Appel et al. · Hypertension · 2004 · 2.1K citations · Full text
John W. Funder, Robert M. Carey, Carlos Fardella et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 1.6K citations · Full text